 Home > Medical News > Latest Medical News > Fosun Pharma’s MEK1/2 inhibitor initiates phase II clinical treatment for type I neurofibromas

Fosun Pharma’s MEK1/2 inhibitor initiates phase II clinical treatment for type I neurofibromas

 Last Update: 2022-01-13
 Source: Internet
 Author: User

Tags

melatonin drug test

rubik's cube free

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Article source: Medical Rubik's Cube Info

Recently, Fosun Pharma issued an announcement stating that it has initiated a phase II clinical study of FCN-159 tablets for the treatment of type I neurofibromas

FCN-159 is an innovative MEK1/2 selective inhibitor independently developed by Fosun Pharma.

Currently, the MEK inhibitors that have been marketed globally include Pfizer's smetinib and binitinib, Exelixis' cobitinib, and Tobacco's trametinib

As of October 2021, Fosun Pharma’s current cumulative R&D investment for this new drug is RMB 108.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.